Lyndal K. Hesterberg

Overview

Lyndal K. Hesterberg received an average of $618K in total compensation, including $152K in salary, at Oncocyte Corp from 2015 to 2019.

Source: SEC filings on May 26, 2020, June 18, 2019, and July 27, 2018.

Related executives

We found 15 more executives who work or worked at Oncocyte Corp.

Ronald Andrews

Oncocyte Corp

Chief Executive Officer

Gisela Paulsen

Oncocyte Corp

Chief Operating Officer

Douglas Ross

Oncocyte Corp

Chief Scientific Officer

Anish John

Oncocyte Corp

Chief Financial Officer

Joshua Riggs

Oncocyte Corp

Chief Executive Officer

James Liu

Oncocyte Corp

Controller and Principal Accounting Officer

Albert Parker

Oncocyte Corp

Chief Operating Officer

Mitchell Levine

Oncocyte Corp

Chief Financial Officer

News

You may also like